Treatment of Severe Atopic Dermatitis With Upadacitinib in Clinical Practice: Short-Term Efficacy and Safety Results

被引：11

作者：

Pereyra-Rodriguez, J. J. ^{[1
,17
]}

Herranz, P. ^{[2
]}

Figueras-Nart, I ^{[3
]}

Perez, B. ^{[4
]}

Elosua, M. ^{[5
]}

Munera-Campos, M. ^{[6
]}

Melgosa-Ramos, J. ^{[7
]}

Zaragoza, V ^{[8
]}

Silvestre, J. F. ^{[9
]}

Campos-Dominguez, M. ^{[10
]}

Guilabert, A. ^{[11
]}

Miquel, J. ^{[12
]}

Alcantara-Luna, S. ^{[13
]}

de la Cueva, P. ^{[14
]}

Serra-Baldrich, E. ^{[15
]}

Armario-Hita, J. C. ^{[16
]}

Rodriguez, Jose Juan Pereyra

机构：

[1] Univ Hosp Virgen Rocio, Dept Dermatol, Seville, Spain

[2] Univ Hosp La Paz, Dept Dermatol, Madrid, Spain

[3] Univ Hosp Bellvitge, Dept Dermatol, Barcelona, Spain

[4] Univ Hosp Ramon & Cajal, Dept Dermatol, Madrid, Spain

[5] Univ Hosp Puerta Hierro, Dept Dermatol, Madrid, Spain

[6] Univ Hosp Germans Trias i Pujol, Dept Dermatol, Badalona, Spain

[7] Univ Hosp Doctor Peset, Dept Dermatol, Valencia, Spain

[8] Univ Hosp Gen Valencia, Dept Dermatol, Valencia, Spain

[9] Univ Hosp Alicante, Dept Dermatol, Alicante, Spain

[10] Univ Hosp Gregorio Maranon, Dept Dermatol, Madrid, Spain

[11] Gen Hosp Granollers, Dept Dermatol, Barcelona, Spain

[12] Univ Hosp Arnau Vilanova, Dept Dermatol, Valencia, Spain

[13] Juan Ramon Jimenez Hosp, Dept Dermatol, Huelva, Spain

[14] Infanta Leonor Hosp, Dept Dermatol, Madrid, Spain

[15] St Pau Hosp, Dept Dermatol, Barcelona, Spain

[16] Univ Hosp Puerto Real, Dept Dermatol, Puerto Real, Spain

[17] Univ Hosp Virgen del Roci, Dept Dermatol, Avda Manuel Siurot S-N, Seville 41013, Spain

来源：

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY | 2023年 / 33卷 / 03期

关键词：

Atopic dermatitis; Atopic eczema; Upadacitinib; JAK-inhibitors; Real-world evidence; DOUBLE-BLIND; ADOLESCENTS; PLACEBO; ADULTS;

D O I：

10.18176/jiaci.0831

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：211 / 213

页数：3

共 50 条

[1] Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results
Pereyra-Rodriguez, Jose-Juan
Herranz, Pedro
Ruiz-Villaverde, Ricardo
Elosua-Gonzalez, Marta
Galan-Gutierrez, Manuel
Figueras-Nart, Ignasi
Miquel, Javier
de la Cueva, Pablo
Serra-Baldrich, Esther
Munera-Campos, Monica
Mele-Ninot, Gemma
Exposito-Serrano, Vicente
Perez, Bibiana
Serrano, Amalia
Ortiz de Frutos, Javier F.
Armario-Hita, Jose C.
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2023, : 991 - 997
[2] The efficacy and safety of upadacitinib treatment for moderate to severe atopic dermatitis in real-world practice in Japan
Hagino, Teppei
Saeki, Hidehisa
Kanda, Naoko
JOURNAL OF DERMATOLOGY, 2022, 49 (11): : 1158 - 1167
[3] Efficacy and safety of upadacitinib in the treatment of moderate-to-severe atopic dermatitis: A systematic review
Zhao, Dan-Jie
Li, Xia
Lin, Hai-Xia
Zheng, Hong
Zhou, Di
Tang, Peng
PLOS ONE, 2024, 19 (07):
[4] Efficacy and Safety of Dupilumab for the Treatment of Severe Atopic Dermatitis in Clinical Practice: A Single Center Experience
Martinez-Domenech, A.
Zaragoza-Ninet, V.
Esteve-Martinez, A.
Garcia-Rabasco, A.
Sanchez-Carazo, J. L.
Perez-Ferriols, A.
ACTAS DERMO-SIFILIOGRAFICAS, 2024, 115 (02): : 150 - 158
[5] Short-term efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis stratified by age
Alexis, A.
Deleuran, M.
Silverberg, J. I.
Gooderham, M.
Johnson, S. L.
Chan, G.
Biswas, P.
Watkins, M.
BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E137 - E138
[6] Efficacy and safety of upadacitinib for the treatment of moderate-to-severe atopic dermatitis: a meta-analysis of randomized clinical trials
Zeng, Linxi
Feng, Sen
Yao, Lulu
Wang, Bin
Zhang, Guoqiang
POSTEPY DERMATOLOGII I ALERGOLOGII, 2023, 40 (06): : 734 - 740
[7] Upadacitinib for the treatment of moderate-to-severe atopic dermatitis in real-world clinical practice
Tran, Vanessa
Ross, Gayle
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 : 11 - 11
[8] First Short-Term Effectiveness and Security Data of Tralokinumab in Severe Atopic Dermatitis in Real Clinical Practice
Castro, Ruben Garcia
Mendaza, Felipe Heras
Sanchez-Mateos, Diana Inmaculada Santiago
Sabris, Maria Carmen Farina
Leon, Inmaculada Alcaraz
DERMATITIS, 2024, 35 (03) : 301 - 303
[9] SHORT-TERM EFFICACY AND SAFETY OF ABROCITINIB BY BASELINE DISEASE SEVERITY IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
Rice, Zakiya P.
Gooderham, Melinda J.
Lebwohl, Mark G.
Simpson, Eric L.
Boguniewicz, Mark
Wollenberg, Andreas
Lazariciu, Irina
Chan, Gary L.
Alderfer, Justine
Watkins, Melissa
ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 30 - 30
[10] Efficacy and Safety of Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Meta-Analysis
Meher, Bikash R.
Mishra, Archana
Behera, Biswanath
Ponnusamy, Subashri
CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)

← 1 2 3 4 5 →